secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapsoVision, Inc (CV)
CIK:        0001378325
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001378325-25-000043
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CapsoVision submits 510(k) to FDA for AI-assisted reading module for CapsoCam Plus
--------------------------------------------------------------------------------

- Submitted 510(k) to FDA for proprietary AI-assisted module for CapsoCam Plus capsule endoscopy system.
- AI module designed to improve detection of clinically significant pathology and reduce clinician review time.
- Company plans to commence U.S. commercialization following FDA clearance.
- CapsoVision claims it is the only capsule endoscopy company with in-house AI core competency.
- Cloud-based architecture eliminates need for on-site servers, reducing cost and IT maintenance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1378325/000137832525000043/0001378325-25-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1378325/000137832525000043/cv-20251229.htm
  HTML page:      https://secwatch.observer/filing/0001378325-25-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer